AdaptHealth Corp. (AHCO), a leading provider of home healthcare equipment and services, saw its stock price surge by 5.08% during intraday trading on Wednesday, February 26th, 2025. The company's strong performance can be attributed to its impressive fourth-quarter 2024 results and positive outlook for 2025, as highlighted in its recent earnings release.
In the fourth quarter of 2024, AdaptHealth reported flat revenue compared to the prior year quarter, but exceeded the midpoint of its guidance by 3%. The Sleep Health and Respiratory Health segments demonstrated year-over-year growth, with Sleep Health revenue increasing by 3.4% and Respiratory Health revenue rising by 1%. While the Diabetes Health segment experienced a 7.3% decline in revenue, the company's adjusted EBITDA and free cash flow exceeded the high end of its guidance ranges.
For the full year 2024, AdaptHealth achieved revenue of $3.26 billion, representing a 1.9% increase over the previous year. The company's adjusted EBITDA grew by 2.7% to $688.7 million, and its net leverage ratio improved to 2.8 times, thanks to a $170 million reduction in debt during the year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。